cesarean section site infectio

Phase 2

Recruiting

• Conditions: Surgical site infection.; T81.4XXA; Infection following a procedure, subsequent encounter

• Registration Number: IRCT20220223054104N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 204

Inclusion Criteria

All women candidate for elective cesarean section in Mahdie hospital

Exclusion Criteria

Patients who do not consent to participate in the study.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence and prevalence of cesarean section site infection. Timepoint: From the time of cesarean section until 30 days later. Method of measurement: Clinical evidence and signs of surgery site infection including fever and chills, erythema, warmth, tenderness, swelling, purulent discharge from the incision site, uterine tenderness and purulent vaginal discharge 24 and 48 hours after surgery and on days 10 and 30 after The action is evaluated by the researcher.